For use in dogs for correction of conditions associated with low circulating thyroid hormone (hypothyroidism).
Veterinary drug approved by the FDA to treat canine hypothyroidism.
Lloyd Laboratories Inc
0.1 mg, 0.2 mg, 0.3 mg, 0.4 mg, 0.5 mg, 0.6 mg, 0.7 mg, and 0.8 mg, and 1.0 mg tablets in bottles of 120.
If any of the following serious side effects occur, stop giving Thyro-Tabs and seek emergency veterinary medical attention; an allergic reaction (swelling of the lips, face, or tongue; difficulty breathing; closing of the throat; or hives). Call your veterinarian if your pet develops any of these serious side effects; sleep problems; personality changes; fever; appetite changes, weight changes. Less serious side effects may be more likely to occur. Continue to use Thyrovet if your pet experiences; cough; loss of appetite; dizziness, drowsiness; sleep problems; dry mouth; nausea, vomiting, diarrhea; itching or rash. Side effects other than those listed here may also occur. Talk to your veterinarian about any side effect that seems unusual or bothersome to the animal.
Store at controlled room temperature: 15°-30°C (59°-86°F) and protect from light.
The initial recommended daily dose is 0.1 to 0.2 mg/10 pounds (4.5 kg) body weight in single or divided doses. Dosage is then adjusted by monitoring the T-4 blood levels of the dog every four weeks until an adequate maintenance dose is established. The usual daily maintenance dose is 0.1 mg/10 lb (4.5 kg). A maximum of 0.8 to 1.0 mg total daily dose will be sufficient in most dogs over 80 pounds in body weight. Thyro-Tabs may be administered orally or placed in the food.
Each Thyro-Tab provides synthetic crystalline Levothyroxine Sodium (L-thyroxine).